Free public records show Azurity in 4 of the markets we cover. It is not a key player in our research.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
46 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
4 recalls since 2015 (4 for medicines)
Source: openFDA, FDA enforcement reports (recalls) naming the firm, since 2015. Retrieved 13 Nov 2026.
Markets we cover where free public records show Azurity: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Azurity is in.
Stories on the topics Azurity works in.
Anaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth…
Read
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read